Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.383NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.117NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.157NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.187NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.120.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.528NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.91 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.617NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.383NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.95 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.189NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.545NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.482NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GY.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JC.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.564NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.461NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.486NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.603NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.606NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.601NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.186NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.324NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.525NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.480NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.214NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.304NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.214.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.577NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.639NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19061.8South Korea
A.2.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.270NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.227NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
U.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used